Y Intercept Hong Kong Ltd Acquires 13,354 Shares of Amdocs Limited $DOX

Y Intercept Hong Kong Ltd raised its holdings in shares of Amdocs Limited (NASDAQ:DOXFree Report) by 568.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,703 shares of the technology company’s stock after purchasing an additional 13,354 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Amdocs were worth $1,433,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of the business. Alyeska Investment Group L.P. lifted its holdings in shares of Amdocs by 38.6% in the 1st quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company’s stock worth $213,174,000 after acquiring an additional 648,693 shares during the last quarter. American Century Companies Inc. lifted its holdings in shares of Amdocs by 23.5% in the 1st quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company’s stock worth $205,219,000 after acquiring an additional 426,911 shares during the last quarter. Nuveen LLC bought a new stake in shares of Amdocs in the 1st quarter worth about $36,921,000. LSV Asset Management lifted its holdings in shares of Amdocs by 11.1% in the 1st quarter. LSV Asset Management now owns 3,180,501 shares of the technology company’s stock worth $291,016,000 after acquiring an additional 317,412 shares during the last quarter. Finally, AQR Capital Management LLC lifted its holdings in shares of Amdocs by 43.0% in the 1st quarter. AQR Capital Management LLC now owns 955,158 shares of the technology company’s stock worth $86,719,000 after acquiring an additional 287,243 shares during the last quarter. Institutional investors own 92.02% of the company’s stock.

Amdocs Trading Up 0.5%

DOX stock opened at $84.26 on Monday. The company has a market capitalization of $9.51 billion, a PE ratio of 17.09, a P/E/G ratio of 1.40 and a beta of 0.51. Amdocs Limited has a 12 month low of $78.61 and a 12 month high of $95.41. The firm’s 50-day moving average is $83.72 and its 200 day moving average is $87.48. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22.

Amdocs (NASDAQ:DOXGet Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, topping the consensus estimate of $1.71 by $0.01. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.13 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The firm’s revenue was down 8.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.62 EPS. On average, research analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th were given a dividend of $0.527 per share. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $2.11 dividend on an annualized basis and a yield of 2.5%. Amdocs’s dividend payout ratio (DPR) is 42.60%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on DOX. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, October 11th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a report on Thursday. Finally, Wolfe Research began coverage on shares of Amdocs in a report on Tuesday, July 8th. They issued an “outperform” rating for the company. Three equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $108.00.

Get Our Latest Stock Report on Amdocs

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Articles

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.